Compound class:
Synthetic organic
Comment: This compound is claimed as an inhibitor of the histone lysine methyltransferase SUV39H2, in Oncotherapy Science's patent WO2017058503A1 [1]. SUV39H2 catalyses the addition of repressive methylation marks on histone 3 at lysine 9 (H3K9).
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Example 203 reduces cell viability in a range of human cancer cell lines [1]. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|